Journal
CURRENT OPINION IN GENETICS & DEVELOPMENT
Volume 48, Issue -, Pages 8-15Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2017.10.004
Keywords
-
Categories
Funding
- US Department of Defense [PC140683]
- US National Institutes of Health [R01CA142776, R01CA190415, P50CA083638, P50CA174523, P50CA083639, P50CA098258]
- Breast Cancer Alliance
- Frank McGraw Memorial Chair in Cancer Research
- American Cancer Society Research Professor Award
- Marsha Rivkin Center for Ovarian Cancer Research
- Basser Center for BRCA
- Harry Fields Professorship
- Kaleidoscope of Hope Ovarian Cancer Foundation
- Ovarian Cancer Research Fund
- Foundation for Women's Cancer
Ask authors/readers for more resources
Sequencing technology has facilitated a new era of cancer research, especially in cancer genomics. Using next-generation sequencing, thousands of long noncoding RNAs (lncRNAs) have been identified as abnormally altered in the cancer genome or differentially expressed in tumor tissues. These lncRNAs are associated with imbalanced gene regulation and aberrant biological processes that contribute to malignant transformation. The functions and therapeutic potential of cancer-related lncRNAs have attracted considerable interest in the past few years. Although few lncRNAs have been well-characterized, researchers have recently made impressive progress in understanding lncRNAs and their novel functions, such as regulation of gene expression, metabolism and DNA repair. These latest findings reinforce the crucial roles of lncRNAs in cancer initiation and development, as well as their possible clinical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available